Catalent
CTLT
#1737
Rank
HK$89.69 B
Marketcap
HK$494.17
Share price
0.00%
Change (1 day)
13.83%
Change (1 year)
Catalent is an American pharmaceutical contract research and development company.

Catalent (CTLT) - Net assets

Net assets on the balance sheet as of September 2024 : HK$27.57 Billion

According to Catalent's latest financial reports the company has HK$27.57 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Catalent - Net assets on balance sheet (from 2013 to 2024)

Net assets by year

Year Net assets Change
2023-06-30$HK$36.13 B-3.57%
2022-06-30$HK$37.46 B12.91%
2021-06-30$HK$33.18 B22.12%
2020-06-30$HK$27.17 B52.02%
2019-06-30$HK$17.87 B109.59%
2018-06-30$HK$8.52 B51%
2017-06-30$HK$5.64 B14.47%
2016-06-30$HK$4.93 B0.41%
2015-06-30$HK$4.91 B-270.54%
2014-06-30$-HK$2.89 Billion-9.45%
2013-06-30$-HK$3.19 Billion16.97%
2012-06-30$-HK$2.73 Billion

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Supernus Pharmaceuticals
SUPN
HK$8.17 B-70.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
-HK$1.28 Billion-104.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Jazz Pharmaceuticals
JAZZ
HK$30.81 B 11.77%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Intercept Pharmaceuticals
ICPT
HK$0.55 B-97.97%๐Ÿ‡บ๐Ÿ‡ธ USA